Jonathan Yon
Stock Analyst at Credit Suisse
(2.06)
# 3,004
Out of 5,113 analysts
16
Total ratings
54.55%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Jonathan Yon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Outperform | $163 → $169 | $205.09 | -17.60% | 3 | Jul 27, 2023 | |
| PRVA Privia Health Group | Reiterates: Outperform | $41 | $23.94 | +71.26% | 2 | Jun 22, 2023 | |
| CYH Community Health Systems | Maintains: Neutral | $8.5 → $7.4 | $3.25 | +127.69% | 1 | May 3, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $31 → $32 | $9.02 | +254.77% | 1 | Feb 23, 2023 | |
| SLQT SelectQuote | Maintains: Neutral | $1 → $3 | $1.64 | +82.93% | 1 | Feb 22, 2023 | |
| MD Pediatrix Medical Group | Maintains: Outperform | $27 → $23 | $21.54 | +6.78% | 3 | Feb 22, 2023 | |
| HCA HCA Healthcare | Maintains: Outperform | $296 → $260 | $470.88 | -44.78% | 1 | Apr 25, 2022 | |
| CLOV Clover Health Investments | Downgrades: Underperform | $9 → $3.5 | $2.59 | +35.14% | 2 | Jan 7, 2022 | |
| CI The Cigna Group | Maintains: Outperform | $270 → $300 | $279.20 | +7.45% | 1 | Nov 8, 2021 | |
| CNC Centene | Maintains: Neutral | $74 → $70 | $46.09 | +51.88% | 1 | Sep 14, 2021 |
Universal Health Services
Jul 27, 2023
Maintains: Outperform
Price Target: $163 → $169
Current: $205.09
Upside: -17.60%
Privia Health Group
Jun 22, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.94
Upside: +71.26%
Community Health Systems
May 3, 2023
Maintains: Neutral
Price Target: $8.5 → $7.4
Current: $3.25
Upside: +127.69%
Cross Country Healthcare
Feb 23, 2023
Maintains: Neutral
Price Target: $31 → $32
Current: $9.02
Upside: +254.77%
SelectQuote
Feb 22, 2023
Maintains: Neutral
Price Target: $1 → $3
Current: $1.64
Upside: +82.93%
Pediatrix Medical Group
Feb 22, 2023
Maintains: Outperform
Price Target: $27 → $23
Current: $21.54
Upside: +6.78%
HCA Healthcare
Apr 25, 2022
Maintains: Outperform
Price Target: $296 → $260
Current: $470.88
Upside: -44.78%
Clover Health Investments
Jan 7, 2022
Downgrades: Underperform
Price Target: $9 → $3.5
Current: $2.59
Upside: +35.14%
The Cigna Group
Nov 8, 2021
Maintains: Outperform
Price Target: $270 → $300
Current: $279.20
Upside: +7.45%
Centene
Sep 14, 2021
Maintains: Neutral
Price Target: $74 → $70
Current: $46.09
Upside: +51.88%